-
EP1290169
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1290169
| EP1290169 - CYSTINE-KNOT POLYPEPTIDES: CLOAKED-2 MOLECULES AND USES THEREOF [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.11.2007 Database last updated on 19.03.2026 | Most recent event Tooltip | 02.11.2007 | Application deemed to be withdrawn | published on 05.12.2007 [2007/49] | Applicant(s) | For all designated states Amgen, Inc. One Amgen Center Drive Thousand Oaks, CA 91320-1799 / US | [N/P] |
| Former [2003/11] | For all designated states Amgen, Inc. One Amgen Center Drive Thousands Oaks, CA 91320-1799 / US | Inventor(s) | 01 /
PASZTY, Christopher, J. 1027 Westride Drive Ventura, CA 93003 / US | 02 /
GAO, Yongming 897 St. Charles Drive, 15 Thousand Oaks, CA 91360 / US | [2003/11] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [N/P] |
| Former [2003/11] | Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE | Application number, filing date | 01939708.2 | 29.05.2001 | [2003/11] | WO2001US17478 | Priority number, date | US20000208550P | 01.06.2000 Original published format: US 208550 P | US20000223542P | 04.08.2000 Original published format: US 223542 P | [2003/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0192308 | Date: | 06.12.2001 | Language: | EN | [2001/49] | Type: | A2 Application without search report | No.: | EP1290169 | Date: | 12.03.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.12.2001 takes the place of the publication of the European patent application. | [2003/11] | Search report(s) | International search report - published on: | EP | 11.04.2002 | Classification | IPC: | C12N15/12, C07K14/47, C07K16/18, G01N33/50, A61K38/17, C12N15/83, C12N15/62, A61K9/00, A01K67/00 | [2003/11] | CPC: |
C07K14/51 (EP,US);
A61P1/04 (EP);
A61P1/16 (EP);
A61P1/18 (EP);
A61P13/12 (EP);
A61P15/06 (EP);
A61P17/02 (EP);
A61P21/04 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P5/06 (EP);
A61P5/14 (EP);
A61P5/40 (EP);
A61P7/00 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61P9/02 (EP);
A61P9/04 (EP);
A61P9/06 (EP);
A61P9/10 (EP);
A61P9/12 (EP);
C07K14/47 (EP,US);
C12Q1/6883 (EP,US);
A01K2217/05 (EP,US);
A61K38/00 (EP,US);
C07K2319/00 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/11] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | CYSTEIN-KNOTEN POLYPEPTIDE: "CLOAKED-2" MOLEKÜLE UND IHRE VERWENDUNGEN | [2003/11] | English: | CYSTINE-KNOT POLYPEPTIDES: CLOAKED-2 MOLECULES AND USES THEREOF | [2003/11] | French: | POLYPEPTIDES A NOEUD DE CYSTINES: MOLECULES "CLOAKED-2" ET LEURS UTILISATIONS | [2003/11] | Biological material | This application mentions deposited biological material, check the file for details | Entry into regional phase | 20.12.2002 | National basic fee paid | 20.12.2002 | Designation fee(s) paid | 20.12.2002 | Examination fee paid | Examination procedure | 20.12.2001 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 20.12.2002 | Amendment by applicant (claims and/or description) | 20.12.2002 | Examination requested [2003/11] | 28.08.2006 | Despatch of a communication from the examining division (Time limit: M09) | 11.06.2007 | Application deemed to be withdrawn, date of legal effect [2007/49] | 16.07.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/49] | Divisional application(s) | EP07009163.2 / EP1857551 | Fees paid | Renewal fee | 13.05.2003 | Renewal fee patent year 03 | 13.05.2004 | Renewal fee patent year 04 | 12.05.2005 | Renewal fee patent year 05 | 23.03.2006 | Renewal fee patent year 06 | 14.05.2007 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PX] BRUNKOW ME ET AL: "Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein", AMERICAN JOURNAL OF HUMAN GENETICS., vol. 68, March 2001 (2001-03-01), AMERICAN SOCIETY OF HUMAN GENETICS, CHICAGO, IL., US, pages 577 - 589, XP001052847, ISSN: 0002-9297 [PX] 1-11,13-15,22,23 * figures 5-7 * DOI: http://dx.doi.org/10.1086/318811 | [PX] BALEMANS W ET AL: "Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)", HUMAN MOLECULAR GENETICS., vol. 10, no. 5, 1 March 2001 (2001-03-01), OXFORD UNIVERSITY PRESS, SURREY., GB, pages 537-543, XP001058218, ISSN: 0964-6906 [PX] 1-11,13-15,22,23 * figure 3 * DOI: http://dx.doi.org/10.1093/hmg/10.5.537 |